These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Determination of antibody levels against coxsackie B virus type 2 and type 3 in sera from blood donors using the microneutralization test]. Kocabeyoğlu O, Toker A, Akça Y, Emekdaş G, Burgu I. Mikrobiyol Bul; 1989 Jul; 23(3):220-4. PubMed ID: 2562136 [Abstract] [Full Text] [Related]
28. Recurrent coxsackie B viral myocarditis leading to progressive impairment of left ventricular function over 8 years. Karavidas A, Lazaros G, Noutsias M, Matzaraki V, Danias PG, Pyrgakis V, Voudris V, Adamopoulos S. Int J Cardiol; 2011 Sep 01; 151(2):e65-7. PubMed ID: 21889035 [No Abstract] [Full Text] [Related]
30. [On the incidence of neutralizing antibodies to Coxsackie viruses in the population (author's transl)]. Jansen P. Med Klin; 1974 Jul 26; 69(30):1265-7. PubMed ID: 4849287 [No Abstract] [Full Text] [Related]
32. Enterovirus infections with beta-cell tropic strains are frequent in siblings of children diagnosed with type 1 diabetes children and in association with elevated levels of GAD65 antibodies. Frisk G, Tuvemo T. J Med Virol; 2004 Jul 26; 73(3):450-9. PubMed ID: 15170642 [Abstract] [Full Text] [Related]